Engineered cells-assisted photoactive nanoparticles delivery for image-guided synergistic photodynamic/photothermal therapy of cancer.

Peng Wang,Wenbo Wu,Ruifang Gao,Han Zhu,Juan Wang,Renle Du,Xiaoyu Li,Chenglan Zhang,Shaokui Cao,Rong Xiang
DOI: https://doi.org/10.1021/acsami.9b00022
IF: 9.5
2019-01-01
ACS Applied Materials & Interfaces
Abstract:Photo-activated therapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is a highly spatiotemporal precise, controllable and noninvasive method for tumor therapy and has therefore attracted increasingly more attention in recent years. However, it is still a challenge to obtain highly efficient therapeutic photoactive agents (PAAs) and deliver them into the tumor, especially the core of solid tumors. Here, we have developed a newly engineered monocyte (MNCs)-based PAA system that realizes precise and highly efficient tumor diagnosis and therapy. Firstly, a near infrared (NIR) emissive PAA molecule with both strong singlet oxygen (1O2) production and high photothermal conversion efficiency was precisely designed for realizing simultaneous PDT and PTT of tumor, and was further fabricated to form PAA nanoparticle (NPs). After loading the PAAs NPs into MNCs, the MNCs were then decorated with cyclic Arg-Gly-Asp (cRGD) groups through metabolic labeling method to further improve their ability of targeting and homing into the deep regions of tumors. By using this strategy, we have achieved highly efficient solid tumor ablation results both in vitro and in vivo, indicating that our strategy has a promising prospective for solid tumor therapy.
What problem does this paper attempt to address?